Search Results - Boles, Jeremiah C

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity

    Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity by Boles, Jeremiah C, Williams, Julie C, Hollingsworth, Rachel M, Wang, Jian-Guo, Glover, Sam L, Owens, A. Phillip, Barcel, David A, Kasthuri, Raj S, Key, Nigel S, Mackman, Nigel

    Published in Thrombosis research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: feasibility and clinical relevance

    Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: feasibility and clinical relevance by Sorah, Jonathan D, Deal, Allison M, Stein, Sophia I, Jonsson, Mattias, Innocenti, Federico, Turk, Anita, Boles, Jeremiah C, Irvin, William, Basch, Ethan M, Sanoff, Hanna K, Wood, William A

    Request full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Clinical Trial of a Portable Electrical Muscle Stimulator (VeinoPlus®) to Improve Symptoms of Postthrombotic Syndrome

    Clinical Trial of a Portable Electrical Muscle Stimulator (VeinoPlus®) to Improve Symptoms of Postthrombotic Syndrome by Soriano, Catherine, Deal, Allison, Boles, Jeremiah C., Moll, Stephan

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer

    A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer by Sanoff, Hanna K, Deal, Allison M, Patel, Jai, Sorah, Jonathan D, Gaddy, Jacquelyne, O’Neil, Bert, Turk, Anita, Irvin, William, Boles, Jeremiah, Lee, Michael S, McRee, Autumn, Wardell, Alexis C, Weck, Karen E, Basch, Ethan, Wood, William A, Innocenti, Federico

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer

    A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer by Sanoff, Hanna K, Deal, Allison M, Patel, Jai, Sorah, Jonathan D, Gaddy, Jacquelyne, ONeil, Bert, Turk, Anita, Irvin, William, Boles, Jeremiah, Lee, Michael S, McRee, Autumn, Wardell, Alexis C, Weck, Karen E, Basch, Ethan, Wood, William A, Innocenti, Federico

    Published in The Oncologist
    Get full text
    Report
    Save to List
    Saved in:
  6. 6
    A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer

    A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer by Sanoff, Hanna K, Deal, Allison M, Patel, Jai, Sorah, Jonathan D, Gaddy, Jacquelyne, ONeil, Bert, Turk, Anita, Irvin, William, Boles, Jeremiah, Lee, Michael S, McRee, Autumn, Wardell, Alexis C, Weck, Karen E, Basch, Ethan, Wood, William A, Innocenti, Federico

    Published in The Oncologist
    Get full text
    Report
    Save to List
    Saved in:

Search Tools: